Prelude Capital Management’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,641
Closed -$66.6K 1603
2025
Q4
$66.6K Buy
11,641
+1,200
+11% +$7.4K ﹤0.01% 1221
2025
Q3
$71.2K Buy
+10,441
New +$79.1K 0.01% 1084
2025
Q1
Sell
-10,558
Closed -$78.7K 1541
2024
Q4
$78.7K Sell
10,558
-3,035
-22% -$25K ﹤0.01% 1118
2024
Q3
$123K Buy
13,593
+147
+1% +$1.52K 0.01% 1137
2024
Q2
$143K Buy
+13,446
New +$143K 0.01% 1059
2021
Q2
Sell
-10,331
Closed -$86K 1981
2021
Q1
$86K Buy
+10,331
New +$73.2K ﹤0.01% 1445
2020
Q4
Sell
-200
Closed -$1K 2017
2020
Q3
$1K Buy
+200
New +$1.31K ﹤0.01% 1737
2019
Q1
Sell
-5,349
Closed -$36K 2197
2018
Q4
$36K Buy
5,349
+3,470
+185% +$25.2K ﹤0.01% 1180
2018
Q3
$15K Sell
1,879
-885
-32% -$8.27K ﹤0.01% 1377
2018
Q2
$27K Sell
2,764
-2,343
-46% -$22.5K ﹤0.01% 1286
2018
Q1
$51K Hold
5,107
﹤0.01% 1064
2017
Q4
$33K Sell
5,107
-2,093
-29% -$14K ﹤0.01% 1024
2017
Q3
$49K Buy
7,200
+3,662
+104% +$24.9K ﹤0.01% 1109
2017
Q2
$25K Buy
+3,538
New +$21.7K ﹤0.01% 1211

Other funds holding ULBI

Prelude Capital Management's ULBI Position: Q1 2026 in Review

Prelude Capital Management sold out of Ultralife (ULBI) in Q1 2026, closing a stake of 11,641 shares — an estimated $66.6K sold.

Prelude Capital Management first reported a position in ULBI in Q2 2017 and held it in 14 quarters. The position peaked at $143K in Q2 2024. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • Prelude Capital Management reported no remaining Ultralife position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 11,641 Ultralife shares in Q1 2026, an estimated $66.6K.
  • Prelude Capital Management first reported a position in Ultralife in Q2 2017 and held it in 14 quarters.
  • Prelude Capital Management's Ultralife position peaked at $143K in Q2 2024.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.